Adaptive designs in clinical trials: why use them, and how to run and report them P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ... BMC medicine 16, 1-15, 2018 | 632 | 2018 |
A simulation study of predictive ability measures in a survival model I: explained variation measures B Choodari‐Oskooei, P Royston, MKB Parmar Statistics in medicine 31 (23), 2627-2643, 2012 | 118 | 2012 |
Review and evaluation of performance measures for survival prediction models in external validation settings MS Rahman, G Ambler, B Choodari-Oskooei, RZ Omar BMC medical research methodology 17, 1-15, 2017 | 100 | 2017 |
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols MKB Parmar, MR Sydes, FH Cafferty, B Choodari-Oskooei, RE Langley, ... Clinical trials 14 (5), 451-461, 2017 | 79 | 2017 |
Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit P Royston, FMS Barthel, MKB Parmar, B Choodari-Oskooei, V Isham Trials 12, 1-18, 2011 | 69 | 2011 |
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of … B Oza, E Frangou, B Smith, H Bryant, R Kaplan, B Choodari-Oskooei, ... Contemporary Clinical Trials 108, 106482, 2021 | 45 | 2021 |
Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate TP Morris, CI Jarvis, W Cragg, PPJ Phillips, B Choodari-Oskooei, ... BMJ open 9 (9), e030215, 2019 | 45 | 2019 |
A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy B Choodari‐Oskooei, P Royston, MKB Parmar Statistics in Medicine 31 (23), 2644-2659, 2012 | 36 | 2012 |
Adding new experimental arms to randomised clinical trials: impact on error rates B Choodari-Oskooei, DJ Bratton, MR Gannon, AM Meade, MR Sydes, ... Clinical Trials 17 (3), 273-284, 2020 | 35 | 2020 |
Point estimation for adaptive trial designs I: A methodological review DS Robertson, B Choodari‐Oskooei, M Dimairo, L Flight, P Pallmann, ... Statistics in medicine 42 (2), 122-145, 2023 | 27 | 2023 |
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome B Choodari-Oskooei, MKB Parmar, P Royston, J Bowden Trials 14, 1-15, 2013 | 27 | 2013 |
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework A Blenkinsop, MKB Parmar, B Choodari-Oskooei Clinical Trials 16 (2), 132-141, 2019 | 26 | 2019 |
Measuring the impact of methodological research: a framework and methods to identify evidence of impact VC Brueton, CL Vale, B Choodari-Oskooei, R Jinks, JF Tierney Trials 15, 1-7, 2014 | 25 | 2014 |
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001 MA Sanjoaquin, B Choodari-Oskooei, C Dolbear, V Putcha, A Sehgal, ... European journal of cancer prevention 16 (1), 10-16, 2007 | 25 | 2007 |
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes DJ Bratton, MKB Parmar, PPJ Phillips, B Choodari-Oskooei Trials 17, 1-8, 2016 | 22 | 2016 |
Combined test versus logrank/Cox test in 50 randomised trials P Royston, B Choodari-Oskooei, MKB Parmar, JK Rogers Trials 20, 1-10, 2019 | 21 | 2019 |
A menu-driven facility for sample-size calculation in multiarm, multistage randomized controlled trials with time-to-event outcomes: Update DJ Bratton, B Choodari-Oskooei, P Royston The Stata Journal 15 (2), 350-368, 2015 | 20 | 2015 |
The epidemiology and treatment of mesothelioma in South East England 1985–2002 V Mak, E Davies, V Putcha, B Choodari-Oskooei, H Møller Thorax 63 (2), 160-166, 2008 | 13 | 2008 |
Multiarm, multistage randomized controlled trials with stopping boundaries for efficacy and lack of benefit: An update to nstage A Blenkinsop, B Choodari-Oskooei The Stata Journal 19 (4), 782-802, 2019 | 10 | 2019 |
Point estimation for adaptive trial designs DS Robertson, B Choodari-Oskooei, M Dimairo, L Flight, P Pallmann, ... arXiv, 2021 | 9 | 2021 |